Skip to main content
Log in

Endostatin/rivoceranib

Hand-foot syndrome and hypertension: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tang H, et al. Successful treatment with apatinib plus human endostatin for refractory recurrent advanced pulmonary carcinosarcoma: A case report. Journal of Thoracic Oncology 12 (Suppl. 2): S2367 abstr. PUB008, No. 11, Nov 2017. Available from: URL: https://doi.org/10.1016/j.jtho.2017.09.1871 [abstract] - China

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Endostatin/rivoceranib. Reactions Weekly 1694, 186 (2018). https://doi.org/10.1007/s40278-018-43587-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-43587-2

Navigation